Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiske Regulatory News (FKE)

Share Price Information for Fiske (FKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.50
Bid: 70.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 15.00 (21.429%)
Open: 77.50
High: 77.50
Low: 77.50
Prev. Close: 77.50
FKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

13 Feb 2013 08:15

RNS Number : 7373X
Fiske PLC
13 February 2013
 



 

 

13 February 2013

 

 

Fiske Plc

('Fiske' or 'the Company')

 

Interim Results

 

Fiske Plc (the 'Company') announces its interim results for the six months ended 30 November 2012. In accordance with rule 26 of the AIM Rules for Companies this information is also available, under the Investors section, at the Company's website, http://www.fiskeplc.com .

 

For further information please contact:

 

• Gerry Beaney/David Hignell Grant Thornton Corporate Finance (Nominated Adviser)

(tel: 020 7383 5100)

 

• Gerard Luchini, Fiske Plc - Compliance Officer

(tel: 020 7448 4700)

 

 

 

Chairman's Statement

  

The only good thing I can say about the results for the half year ending 30th November 2012 is that the final figure is a plus, albeit a figure so small as to be insignificant. As I am sure shareholders are aware the period under review has been a particularly difficult time to make profits in our business. Basically we have broken even, a totally unacceptable outcome. I can assure you that we are taking steps to reduce costs by a target of 5% and equally to boost income of the same proportion.

 

It is true that most Stockbrokers have fallen on bad times, mostly because they relied heavily on corporate finance fees. We are not in that position as we regard corporate finance business as having a huge conflict of interest with advising private client funds.

 

The image of private client stockbrokers has been badly affected by recent events and we continue to stress our old fashioned emphasis on value for money and integrity. In that context it is important to accept that more activity can only be justified if it is in the client's best interest. This has affected our short term results, but we are confident that many interesting opportunities will arise and our clients will be in a position to take advantage of them.

 

In addition to our private client department, where we are, as always, in discussions to add to our advisors, we have a healthy institutional business. We have strengthened this side of the firm with a new unit, Baden Hill, which is establishing itself as a distinctive and expanding element in that area.

 

In view of the disappointing level of profit, we will only be paying a token interim dividend of ¼p per share.

 

 

C F Harrison Chairman

13 February 2013

 

 

 

Consolidated Statement of Comprehensive Income

for the six months ended 30 November 2012

 

 

 

Six months ended

30 November 2012

Unaudited

Six months ended

30 November 2011

Unaudited

Year ended

31 May 2012

Audited

£'000

£'000

£'000

Fee and commission income

1,779

1,866

3,671

Fee and commission expenses

(463)

(408)

(865)

Net fee and commission income

1,316

1,458

2,806

Other income

109

102

161

Total revenue

1,425

1,560

2,967

Profit on investments held for trading

54

7

24

Operating expenses

(1,511)

(1,455)

(2,963)

Operating profit

(32)

112

28

Investment revenue

26

28

34

Finance income

11

13

26

Finance costs

-

(1)

(2)

Profit on ordinary activities before taxation

5

152

86

Taxation

(3)

(29)

(17)

Profit on ordinary activities after taxation

2

123

69

Other comprehensive income/(expense)

Movement in unrealised appreciation of investments

1

(2)

(5)

Deferred tax on movement in unrealised appreciation of investments

 

-

 

1

 

23

Net other comprehensive (loss)/income

1

(1)

18

Total comprehensive income for the period/year attributable to equity shareholders

 

3

 

122

 

87

Earnings per ordinary share (pence)

Basic

0.0p

1.5p

0.8p

Diluted

0.0p

1.5p

0.8p

 

All results are from continuing operations and are attributable to equity shareholders of the parent company.

Consolidated Statement of Changes in Equity

 

 

 

 

Share Capital

Share Premium

Revaluation Reserve

Retained Earnings

Total Equity

£'000

£'000

£'000

£'000

£'000

Balance at 1 December 2011

2,115

1,222

755

513

4,605

Loss on ordinary activities after taxation

-

-

-

(54)

(54)

Other comprehensive income

-

-

19

-

19

Total comprehensive income/(loss) for period

-

-

19

(54)

(35)

Dividends paid

-

-

-

(169)

(169)

Balance at 31 May 2012

2,115

1,222

774

290

4,401

Profit on ordinary activities after taxation

-

-

-

2

2

Other comprehensive loss

-

-

1

-

1

Total comprehensive income for period

-

-

1

2

3

Dividends paid

-

-

-

(85)

(85)

Balance at 30 November 2012

2,115

1,222

775

207

4,319

 

Consolidated Statement of Financial Position

30 November 2012

 

 

 

As at

30 November 2012

Unaudited

As at

30 November 2011

Unaudited

As at

31 May 2012

Audited

£'000

£'000

£'000

Non-current assets

Goodwill

395

395

395

Property, plant and equipment

53

46

37

Available-for-sale investments

1,225

1,227

1,223

Total non-current assets

1,673

1,668

1,655

Current assets

Trade and other receivables

4,492

6,193

5,781

Investments held for trading

201

237

251

Cash and cash equivalents

3,278

3,498

3,236

Total current assets

7,971

9,928

9,268

Current liabilities

Trade and other payables

5,074

6,565

6,274

Current tax liabilities

24

175

24

Total current liabilities

5,098

6,740

6,298

Net current assets

2,873

3,188

2,970

Non-current liabilities

Deferred tax liabilities

227

251

224

Total non-current liabilities

227

251

224

Net assets

4,319

4,605

4,401

Equity

Share capital

2,115

2,115

2,115

Share premium

1,222

1,222

1,222

Revaluation reserve

775

755

774

Retained earnings

207

513

290

Shareholders' equity

4,319

4,605

4,401

 

Consolidated Cash Flow Statement

For the six months ended 30 November 2012

 

 

 

Six months ended

30 November 2012

Unaudited

Six months ended

30 November 2011

Unaudited

Year ended

31 May 2012

Audited

£'000

£'000

£'000

Operating (loss)/profit

(32)

112

28

Depreciation of property plant and equipment

19

14

30

Decrease in investments held for trading

50

47

33

Decrease in receivables

1,289

5,554

5,966

Decrease in payables

(1,200)

(5,555)

(5,846)

Cash generated from operations

126

172

211

Tax paid

-

-

(143)

Net cash generated from operating activities

126

172

68

Investing activities

Interest received

11

13

26

Investment income received

26

28

34

Interest paid

-

(1)

(2)

Purchases of property, plant and equipment

(36)

(3)

(10)

Net cash generated from investing activities

1

37

48

Financing activities

Dividends paid

(85)

(169)

(338)

Net cash used in financing activities

(85)

(169)

(338)

Net increase in cash and cash equivalents

42

40

(222)

Cash and cash equivalents at beginning of period

3,236

3,458

3,458

Cash and cash equivalents at end of period/year

3,278

3,498

3,236

 

 

Notes to the Interim Financial Statements

1. Basis of preparation

The financial information contained in this half-yearly financial report does not constitute statutory accounts as defined in section 434 of the Companies Act 2006.

The figures and financial information for the period ended 31 May 2012 are extracted from the latest published audited financial statements of the Group and do not constitute the statutory financial statements for that period. The audited financial statements for the period ended 31 May 2012 have been filed with the Registrar of Companies. The report of the independent auditors on those financial statements contained no qualification or statement under section 498(2) or section 498(3) of the Companies Act 2006.

The condensed set of financial statements has been prepared using accounting policies consistent with International Financial Reporting Standards (IFRSs) as adopted by the European Union. The financial information has been prepared under the historical cost convention, except for the revaluation of certain financial instruments. The same accounting policies, presentation and methods of computation are followed in these condensed set of financial statements as applied in the Group's latest, and intends to use in preparing its next, annual audited financial statements. While the financial figures included in this half-yearly report have been computed in accordance with IFRSs applicable to interim periods, this half-yearly report does not contain sufficient information to constitute an interim financial report as that term is defined in IAS 34.

The directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing this half-yearly financial report.

2. Taxation

The tax charge for the six months to 30 November 2012 reflects all the necessary provisions for current tax, taking into account the availability of losses brought forward, and movements in deferred tax. In arriving at the effective tax rate account has been taken of the change in the rate of tax charged and the disallowance of the cost of share-based payments charged to the consolidated statement of comprehensive income.

3. Dividends paid

Dividends paid of £85,000 (2011 - £169,000) refer to the second interim dividend paid for the preceding year.

The Interim dividend of 0.25p will be paid on 22 March 2013 to shareholders on the register on 22 February 2013. The shares will be marked ex-dividend on 20 February 2013.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFVRFIIFLIV
Date   Source Headline
15th Apr 20244:27 pmRNSDirector Dealing
6th Mar 202411:51 amRNSDirector Dealing
22nd Feb 20241:21 pmRNSDirector Dealing
19th Feb 20244:38 pmRNSDirector Dealing
16th Feb 20242:47 pmRNSDirector Dealing
16th Feb 20247:00 amRNSInterim results
8th Dec 20234:56 pmRNSDirector Dealing
28th Nov 20233:38 pmRNSDirector Dealing
23rd Nov 202312:52 pmRNSResult of AGM and Confirmation of Board Changes
30th Oct 20233:42 pmRNSDirector Dealing
24th Oct 20237:00 amRNSFinal Results, Annual Report and Notice of AGM
22nd Aug 20231:19 pmRNSDirector dealing
6th Jul 20237:00 amRNSDirector Dealing
31st May 20233:27 pmRNSDirector Dealing
4th Apr 202312:38 pmRNSDirector Dealing
3rd Apr 202310:55 amRNSDirector Dealing
3rd Apr 20237:00 amRNSAcquisition of Client Book
2nd Mar 20237:00 amRNSInterim results
29th Nov 20221:58 pmRNSDirector Dealings
24th Nov 20225:31 pmRNSResult of AGM
20th Oct 20227:00 amRNSFinal Results, Annual Report and Notice of AGM
18th Aug 20229:30 amRNSHolding(s) in Company
17th Jun 20224:13 pmRNSDirector Dealing
1st Mar 20227:00 amRNSHalf-year Report
17th Dec 20214:47 pmRNSDirector Dealing
10th Dec 20217:00 amRNSChange to Accounting Year End
30th Nov 20217:00 amRNSChange of Registered Office
25th Oct 202110:56 amRNSResult of AGM
30th Sep 202111:23 amRNSTotal Voting Rights
29th Sep 20215:29 pmRNSDirector Dealing
17th Sep 20211:08 pmRNSDirector Shareholding & Director Dealing
17th Sep 20219:58 amRNSExercise of Share Options and Issue of Equity
14th Sep 20219:44 amRNSFinal Results, Annual Report and Notice of AGM
5th Jul 202112:56 pmRNSHolding(s) in Company
28th May 20214:21 pmRNSDirector Dealings and Director Shareholding Update
20th Apr 20217:00 amRNSDirector Shareholding Disclosure
19th Feb 20217:00 amRNSInterim Results
8th Feb 20215:28 pmRNSForm 8.3 - Marston's PLC
23rd Dec 20202:46 pmRNSResult of AGM
3rd Dec 202010:01 amRNSDirector Dealing
30th Nov 202012:20 pmRNSIssue of Equity
30th Nov 20207:00 amRNSFinal Results, Posting of Report and Notice of AGM
16th Nov 20207:30 amRNSSale of Euroclear shares
12th Nov 202011:31 amRNSSale of Euroclear shares
22nd Sep 20202:41 pmRNSForm 8.3 - Deltic Energy Plc
27th Jul 20203:54 pmRNSForm 8.3 - Deltic Energy Plc
16th Jul 20207:00 amRNSDirector Retirement
8th Apr 20207:00 amRNSCovid-19 and Trading Update
10th Mar 20209:57 amRNSDirector Dealing
26th Feb 20207:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.